{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:34:29Z","timestamp":1792661669105,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ebiom.2024.105244","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T01:01:07Z","timestamp":1721178067000},"page":"105244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Predicting Clostridioides difficile infection outcomes with explainable machine learning"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-3156","authenticated-orcid":false,"given":"Gregory R.","family":"Madden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-4202","authenticated-orcid":false,"given":"Rachel H.","family":"Boone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costi D.","family":"Sifri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105244_bib1","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. Burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105244_bib2","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the infectious diseases society of America (IDSA) and society for healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib3","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1093\/ofid\/ofy210.498","article-title":"Validation of the SHEA\/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridium difficile infection","volume":"5","author":"Stevens","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00676-22","article-title":"Validation of clinical risk models for Clostridioides difficile-attributable outcomes","volume":"66","author":"Madden","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ebiom.2024.105244_bib5","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/1471-2334-13-148","article-title":"Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy","volume":"13","author":"Miller","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820977385","article-title":"External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection","volume":"14","author":"van Rossen","year":"2021","journal-title":"Ther Adv Gastroenter"},{"key":"10.1016\/j.ebiom.2024.105244_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijantimicag.2017.09.010","article-title":"Prediction of recurrent clostridium difficile infection at the bedside: the GEIH-CDI score","volume":"51","author":"Cobo","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ebiom.2024.105244_bib8","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/cid\/cis356","article-title":"Predictors of first recurrence of Clostridium difficile infection: implications for initial management","volume":"55","author":"Eyre","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib9","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/cid\/ciu107","article-title":"Risk estimation for recurrent Clostridium difficile infection based on clinical factors","volume":"58","author":"D\u2019Agostino","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/phar.2088","article-title":"Derivation and validation of a Clostridium difficile infection recurrence prediction rule in a national cohort of veterans","volume":"38","author":"Reveles","year":"2018","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.ebiom.2024.105244_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10096-015-2549-9","article-title":"First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis","volume":"35","author":"Larrainzar-Coghen","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib12","first-page":"495","article-title":"Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system","volume":"55","author":"Belmares","year":"2007","journal-title":"J\u00a0Infection"},{"key":"10.1016\/j.ebiom.2024.105244_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib14","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.cgh.2013.04.050","article-title":"Clinical factors associated with development of severe-complicated Clostridium difficile infection","volume":"11","author":"Shivashankar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2024.105244_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123405","article-title":"A\u00a0multi-center prospective derivation and validation of a clinical prediction tool for severe Clostridium difficile infection","volume":"10","author":"Na","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2024.105244_bib16","doi-asserted-by":"crossref","first-page":"O301","DOI":"10.1111\/1469-0691.12391","article-title":"Predicting a complicated course of Clostridium difficile infection at the bedside","volume":"20","author":"Hensgens","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ebiom.2024.105244_bib17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00092-23","article-title":"Novel biomarkers, including tcdB PCR cycle threshold, for predicting recurrent Clostridioides difficile infection","volume":"91","author":"Madden","year":"2023","journal-title":"Infect Immun"},{"key":"10.1016\/j.ebiom.2024.105244_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/ice.2018.53","article-title":"Reduced Clostridium difficile tests and laboratory-identified events with a computerized clinical decision support tool and financial incentive","volume":"39","author":"Madden","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ebiom.2024.105244_bib20","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1007\/s10620-009-1074-z","article-title":"Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans","volume":"55","author":"Thirumurthi","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ebiom.2024.105244_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/jamasurg.2018.3174","article-title":"Development and validation of a prediction model for mortality and adverse outcomes among patients with peripheral eosinopenia on admission for Clostridium difficile infection","volume":"153","author":"Kulaylat","year":"2018","journal-title":"Jama Surg"},{"key":"10.1016\/j.ebiom.2024.105244_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ebiom.2024.105244_bib23","series-title":"Proc 21st ACM SIGPLAN int conf funct program","article-title":"Large-scale machine learning on heterogeneous distributed systems","author":"Abadi","year":"2016"},{"key":"10.1016\/j.ebiom.2024.105244_bib24","first-page":"2825","article-title":"Scikit-learn: machine learning in Python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J\u00a0Mach Learn Res"},{"key":"10.1016\/j.ebiom.2024.105244_bib25","article-title":"A\u00a0unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"arXiv"},{"key":"10.1016\/j.ebiom.2024.105244_bib26","doi-asserted-by":"crossref","first-page":"e1467","DOI":"10.1093\/cid\/ciac624","article-title":"Stool interleukin-1\u03b2 differentiates Clostridioides difficile infection (CDI) from asymptomatic carriage and non-CDI diarrhea","volume":"76","author":"G\u00e1lvez","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/mBio.00180-20","article-title":"Systemic inflammatory mediators are effective biomarkers for predicting adverse outcomes in Clostridioides difficile infection","volume":"11","author":"Dieterle","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2024.105244_bib28","first-page":"ciab826","article-title":"Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection","volume":"74","author":"Alonso","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105244_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.711809","article-title":"Systematic review on the correlation of quantitative PCR cycle threshold values of gastrointestinal pathogens with patient clinical presentation and outcomes","volume":"8","author":"Bonacorsi","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.ebiom.2024.105244_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1017\/ice.2017.176","article-title":"Prediction of recurrent Clostridium difficile infection using comprehensive electronic medical records in an integrated healthcare delivery system","volume":"38","author":"Escobar","year":"2017","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424002809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T23:34:57Z","timestamp":1724283297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424002809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":30,"alternative-id":["S2352396424002809"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105244","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting Clostridioides difficile infection outcomes with explainable machine learning","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105244"}}